A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

Inclusion Criteria: * Healthy, nonsmoking, male and/or female subjects of non-childbearing potential. * Body Mass Index (BMI) of 17.5 to 30.5 kg/m2. * Total body weight \>50 kg (110 lbs). Exclusion Criteria: * Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease. * An ALT or AST measurement \>2 times the ULN. * 12-lead ECG demonstrating QTc \>450 msec or a QRS interval \>120 msec at Screening. * Subjects at increased risk if dosed with moxifloxacin, according to the product label for moxifloxacin. * History of risk factors of QT prolongation or torsades de pointes, congenital deafness and family history of sudden death.